OTCMKTS:KALTF

Claritas Pharmaceuticals Short Interest Ratio and Short Volume

$0.02
0.00 (-13.39 %)
(As of 06/23/2021 01:22 PM ET)
Add
Compare
Today's Range
$0.02
$0.03
50-Day Range
$0.02
$0.06
52-Week Range
$0.00
$0.10
Volume267,815 shs
Average Volume842,101 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Claritas Pharmaceuticals (OTCMKTS:KALTF) Short Interest Data

Current Short Volume100 shares
Previous Short Volume21,900 shares
Change Vs. Previous Month-99.54%
Dollar Volume Sold Short$3.70
Short Interest Ratio / Days to Cover0.0
Last Record DateMay, 28 2021
Outstanding Shares701,400,000 shares
Percentage of Shares Shorted
Today's Trading Volume267,815 shares
Average Trading Volume842,101 shares
Today's Volume Vs. Average-68.20%

Short Interest Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Claritas Pharmaceuticals ?

Sign up to receive the latest short interest report for Claritas Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Claritas Pharmaceuticals (OTCMKTS:KALTF) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/28/2021100 shares $3.70 -99.5%N/A0 $0.04
5/14/202121,900 shares $628.53 +305.6%N/A0 $0.03
4/30/20215,400 shares $194.40 -22.9%N/A0 $0.04
4/15/20217,000 shares $385.00 -95.8%N/A0 $0.06
3/31/2021167,800 shares $5,873.00 +6,891.7%N/A0.3 $0.04
3/15/20212,400 shares $94.80 +2,300.0%N/A0 $0.04
2/26/2021100 shares $2.50 No ChangeN/A0 $0.03
5/15/20207,500 shares $90.00 -15.7%N/A0.1 $0.01
4/30/20208,900 shares $102.35 +888.9%N/A0.1 $0.01
4/15/2020900 shares $11.70 -96.7%N/A0 $0.01
3/31/202027,500 shares $247.50 -85.9%N/A0 $0.01
3/13/2020195,500 shares $4,398.75 +272.4%N/A0.4 $0.02
2/28/202052,500 shares $1,575.00 -59.1%N/A0.4 $0.03
2/14/2020128,400 shares $4,301.40 +126.1%N/A0.7 $0.03
1/31/202056,800 shares $1,931.20 -49.0%N/A0.5 $0.03
1/15/2020111,300 shares $3,951.15 +192.9%N/A0.6 $0.04
12/31/201938,000 shares $1,330.00 +3.3%N/A0.3 $0.04

Claritas Pharmaceuticals (OTCMKTS:KALTF) Short Interest FAQ

speech bubbles
speech bubbles











What is Claritas Pharmaceuticals' current short interest?

Short interest is the volume of Claritas Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 28th, traders have sold 100 shares of KALTF short.

Is Claritas Pharmaceuticals' short interest increasing or decreasing?

Claritas Pharmaceuticals saw a decrease in short interest in the month of May. As of May 28th, there was short interest totaling 100 shares, a decrease of 99.5% from the previous total of 21,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Claritas Pharmaceuticals' short interest compare to its competitors?

0.00% of Claritas Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Claritas Pharmaceuticals: Abattis Bioceuticals Corp. (0.00%), Algernon Pharmaceuticals Inc. (0.00%), Almirall, S.A. (0.00%), Ascletis Pharma Inc. (0.00%), AXIM Biotechnologies, Inc. (0.00%), BerGenBio ASA (0.00%), Cannabics Pharmaceuticals Inc. (0.00%), Cassiopea S.p.A. (0.00%), Cerebain Biotech Corp. (0.00%), and Clinuvel Pharmaceuticals Limited (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($25.04 billion), AstraZeneca PLC ($7.50 billion), Aon plc ($7.09 billion), Square, Inc. ($6.95 billion), Analog Devices, Inc. ($6.90 billion), Advanced Micro Devices, Inc. ($6.79 billion), Charter Communications, Inc. ($6.18 billion), S&P Global Inc. ($5.54 billion), Sea Limited ($4.96 billion), and Wayfair Inc. ($4.25 billion). View all of the most shorted stocks.

What does it mean to sell short Claritas Pharmaceuticals stock?

Short selling KALTF is an investing strategy that aims to generate trading profit from Claritas Pharmaceuticals as its price is falling. Claritas Pharmaceuticals' stock is trading down $0.00 today. To short Claritas Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Claritas Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Claritas Pharmaceuticals?

A short squeeze for Claritas Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KALTF, which in turn drives the price of the stock up even further.

How often is Claritas Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALTF, twice per month. The most recent reporting period available is May, 28 2021.



This page was last updated on 6/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.